Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Teishima

Showing results (111-120 of 240) with videos related to

Pageof 24
Sort By:
Maturitas|September 2, 2006
Women's perception of male erectile dysfunction drugs in the general populationKoji Mita, Masanobu Shigeta, Masayuki Kakehashi, et al.
Molecular and Clinical Oncology|March 21, 2014
Expression of <i>miR-486</i> is a potential prognostic factor after nephrectomy in advanced renal cell carcinomaKeisuke Goto, Naohide Oue, Shunsuke Shinmei, et al.
Anticancer Research|July 31, 2020
The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical CystectomyKenshiro Takemoto, Jun Teishima, Yuki Kohada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 20, 2018
Prospective study of robotic partial nephrectomy for renal cancer in Japan: Comparison with a historical control undergoing laparoscopic partial nephrectomyKazushi Tanaka, Jun Teishima, Atsushi Takenaka, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|August 19, 2011
Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasionTetsutaro Hayashi, Naohide Oue, Naoya Sakamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 23, 2017
Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancerKohei Kobatake, Tetsutaro Hayashi, Peter C Black, et al.
International Cancer Conference Journal|December 15, 2025
Pathologic complete response to enfortumab vedotin plus pembrolizumab in node-positive urothelial carcinoma: a case reportTakuto Hara, Eiki Inoue, Naoto Wakita, et al.
Anticancer Research|March 4, 2025
Genomic Profiling of Small Cell Neuroendocrine Prostate Cancer and its Implications for Targeted TherapiesJunichiro Hirata, Takuto Hara, Naoe Jimbo, et al.
BMC Cancer|February 5, 2025
Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trialJunya Furukawa, Yasumasa Kakei, Sae Murakami, et al.
International Cancer Conference Journal|October 14, 2024
A pathological complete response and adrenal insufficiency in a patient with advanced renal pelvic cancer treated with pembrolizumabKotaro Suzuki, Kazuki Murata, Naoto Wakita, et al.
Pageof 24

Showing results (111-120 of 240) with videos related to

Sort By:
Pageof 24
Maturitas|September 2, 2006
Women's perception of male erectile dysfunction drugs in the general populationKoji Mita, Masanobu Shigeta, Masayuki Kakehashi, et al.
Molecular and Clinical Oncology|March 21, 2014
Expression of <i>miR-486</i> is a potential prognostic factor after nephrectomy in advanced renal cell carcinomaKeisuke Goto, Naohide Oue, Shunsuke Shinmei, et al.
Anticancer Research|July 31, 2020
The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical CystectomyKenshiro Takemoto, Jun Teishima, Yuki Kohada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 20, 2018
Prospective study of robotic partial nephrectomy for renal cancer in Japan: Comparison with a historical control undergoing laparoscopic partial nephrectomyKazushi Tanaka, Jun Teishima, Atsushi Takenaka, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|August 19, 2011
Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasionTetsutaro Hayashi, Naohide Oue, Naoya Sakamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 23, 2017
Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancerKohei Kobatake, Tetsutaro Hayashi, Peter C Black, et al.
International Cancer Conference Journal|December 15, 2025
Pathologic complete response to enfortumab vedotin plus pembrolizumab in node-positive urothelial carcinoma: a case reportTakuto Hara, Eiki Inoue, Naoto Wakita, et al.
Anticancer Research|March 4, 2025
Genomic Profiling of Small Cell Neuroendocrine Prostate Cancer and its Implications for Targeted TherapiesJunichiro Hirata, Takuto Hara, Naoe Jimbo, et al.
BMC Cancer|February 5, 2025
Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trialJunya Furukawa, Yasumasa Kakei, Sae Murakami, et al.
International Cancer Conference Journal|October 14, 2024
A pathological complete response and adrenal insufficiency in a patient with advanced renal pelvic cancer treated with pembrolizumabKotaro Suzuki, Kazuki Murata, Naoto Wakita, et al.
Pageof 24